Results 141 to 150 of about 113,997,697 (174)

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses. [PDF]

Euro Surveill
Dapat C, Peck H, Jelley L, Diefenbach-Elstob T, Slater T, Hussain S, Britton P, Cheng AC, Wood T, Howard-Jones A, Deng YM, Miller JE, Huang QS, Barr IG.   +13 more
europepmc   +1 more source

Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021-2023, and Characterization of Newly Emerged Virus Clades. [PDF]

J Med Virol
Duwe S, Oh DY, Wedde M, Börnigen D, Ignatius R, Kleist MV, Reiche J, Biere B, Wolff T, Dürrwald R.   +9 more
europepmc   +1 more source

Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025-2026 season. [PDF]

J Assoc Med Microbiol Infect Dis Can
Sabaiduc S, Kaweski SE, Separovic L, Gao R, Ranadheera C, Bastien N, Skowronski DM.   +6 more
europepmc   +1 more source

Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025. [PDF]

Euro Surveill
Cheng SM, Leung NH, Shiu EY, Wong RW, Au NY, Huang X, Kwok NK, Chan CH, Li JK, Tsang LC, Kwan TC, Tsang TK, Poon LL, Cowling BJ, Peiris M.   +14 more
europepmc   +1 more source

Sex differences in antibody responses to influenza A/H3N2 across the life course

Metcalf CJ, Chen S, García-Carreras B, Hay J, Zhu H, Jiang C, Kwok K, Riley S, Read J, Lessler J, Cummings D.   +10 more
europepmc   +1 more source

Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025. [PDF]

Euro Surveill
Guiomar R, Henriques C, Pereira da Silva S, Gomes L, Dias D, Verdasca N, Portuguese Laboratory Network for the Diagnosis of Influenza and Respiratory Viruses, Nunes B, Rodrigues AP.   +8 more
europepmc   +1 more source

Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K. [PDF]

Euro Surveill
Kirsebom FC, Thompson C, Talts T, Kele B, Whitaker HJ, Andrews N, Abdul Aziz N, Rawlinson C, Green RE, Quinot C, Gardner N, Waller E, Allen A, Watson CH, McDonald SL, Zambon M, Pebody R, Ramsay M, Hoschler K, Singanayagam A, Lopez Bernal J.   +20 more
europepmc   +1 more source

Influenza A(H3N2) subclade K (J.2.4.1) viruses associated with a surge at a university health clinic, Arizona, the United States, November to early December 2025. [PDF]

Euro Surveill
Scotch M, Faleye TO, Urquidez-Negrete A, Bobbett B, Boyle V, Conard K, Sublasky-Rodriguez L, Murugan V.   +7 more
europepmc   +1 more source

Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025.

Euro Surveill
Shen Y, Zhang D, Feng Z, Ma C, Shi W, Duan W, Li J, Zhang L, Wu D, Zhang J, Ma J, Wang Y, Hu X, Yan S, Di Y, Zhao J, Xu H, Wang Q, Yang P.   +18 more
europepmc   +1 more source

Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study. [PDF]

Clin Infect Dis
Rojas RE, Equils O, Villacian J, Mann A, van Duijnhoven W, Vingerhoets J, Baguet T, Wang SS, Anandakumar A, Anger A, Tourneroche A, Silva IG, Flanagan S.   +12 more
europepmc   +1 more source